# ALHEMO
> **BLA761315** · Biologics License Application · Sponsor: NOVO NORDISK INC · Approved 2024-12-20
## Drug
- **FDA Application Number:** BLA761315
- **Application type:** Biologics License Application
- **Brand name:** ALHEMO
- **Generic name:** CONCIZUMAB
- **Active ingredients:** CONCIZUMAB-MTCI
- **Dosage form:** Injectable
- **Route:** Subcutaneous
- **Marketing status:** Prescription
- **Sponsor:** NOVO NORDISK INC
- **Manufacturer:** Novo Nordisk
- **First approval:** 2024-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761315)
---
*MORVS · CC0 1.0*